Obstructive sleep apnea syndrome: Who should be treated?

Sleep

Volumn 23, Issue SUPPL. 4, 2000, Pages

  McNicholas, Walter T ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DISEASE SEVERITY; HEALTH CARE FINANCING; HUMAN; MANDIBLE PROSTHESIS; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PATIENT SELECTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; TREATMENT INDICATION; UVULOPALATOPHARYNGOPLASTY;

CARDIOVASCULAR DISEASES; DEPRESSION; DISORDERS OF EXCESSIVE SOMNOLENCE; HUMANS; POSITIVE-PRESSURE RESPIRATION; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; SOMATOFORM DISORDERS;

EID: 0034659196     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Partinen M. Epidemiology of sleep disorders. In: Kryger MH, Roth T Dement WC, Eds. Principles and practice of sleep medicine. 2nd. Ed. Philadelphia, WB Saunders, 1994; 437-452.
2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230-1235.
3. Engleman, H.M., Martin, S.E., Deary, I.J., Douglas, N.J. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343:572-575.
4. McEvoy RD, Thornton AT. Treatment of obstructive sleep apnea syndrome with nasal continuous positive airway pressure. Sleep 1988; 7:313-325.
5. Engleman, H.M., Asgari-Jirhandeh, N., McLeod, A.L., Ramsay, C.F., Deary, I.J., Douglas, N.J. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996; 109:1470-1476.
6. Hardinge, F.M., Pitson, D.J., Stradling, J.R. Use of the Epworth sleepiness scale to demonstrate response to treatment with nasal continuous positive airways pressure in patients with obstructive sleep apnoea. Respir.Med. 1995; 89:617-620.
7. Krieger J, Kurtz D. Objective measurement of compliance with nasal CPAP treatment for obstructive sleep apnea syndrome. Eur Respir J 1988; 1:436-8.
8. Rauscher H, Formanek D, Popp W, Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993;103:1675-80.
9. Reeves-Hoche MK, Meek R, Zwillich CW. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994; 149:149-154.
10. McNicholas WT. Compliance with nasal CPAP in obstructive sleep apnoea: how much is enough ? Eur Resp J 1997; 10:969-970
11. Wright, J., Johns, R., Watt, I., Melville, A., Sheldon, T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ. 1997; 314:851-860.
12. Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenberg C. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 1998; 157:858-865.
13. Engleman, H.M., Martin, S.E., Deary, I.J., Douglas, N.J. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997; 52:114-119.
14. McEvoy RD, Sharp DJ, Thornton AT. The effects of posture on obstructive sleep apnea. Am Rev Respir Dis 1986; 133:662-666.
15. Smith PL, Gold AR, Meyers DA et al. Weigth loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985;103:850-55
16. Sullivan CE, Issa FG, Berthon-Jones M, McCauley VB, Costas LJ. Home treatment of obstructive sleep apnoea with continuous positive airway pressure applied through a nose mask. Bull Eur Physiopsyhol Respir 1984; 20:49-54
17. Hoffstein, V., Viner, S., Mateika, S., Conway, J. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure, patient compliance, perception of benefits, and side effects. Am.Rev.Respir.Dis. 1992; 145:841-845.
18. Sforza E, Krieger J. Daytime sleepiness after long-term continuous positive airway pressure treatment in obstructive sleep apnea syndrome. J Neurol Sci 1992; 110:21-26.
19. Sforza E, Lugaresi E. Daytime sleepiness and nasal continuous positive airway pressure therapy in obstructive sleep apnea syndrome patients: effects of chronic treatment and 1-night therapy withdrawal. Sleep 1995; 18:195-201.
20. Jenkinson C, Stradling J, Petersen S. Comparison of three measures of quality of life outcome in the evaluation of continuous positive airways pressure therapy for sleep apnoea. J Sleep Res 1997; 6:199-204.
21. Kiely, J.L., McNicholas, W.T. Bed partners' assessment of nasal continuous positive airway pressure therapy in obstructive sleep apnea. Chest 1997; 111:1261-1265.
22. Lojander J, Maasilta P, Partinen M, Brander PE, Salmi T, Lehtonen H. Nasal CPAP, surgery, and conservative management for treatment of obstructive sleep apnea syndrome. A randomised study. Chest 1996; 110:114-119.
23. Millman RP, Fogel BS, McNamara ME, Carlisle CC. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J CLIN PSYCHIATRY 1989; 50:348-351.
24. Edinger JD, Carwile S, Miller P, Hope V, Mayti C. Psychological status, syndromatic measures, and compliance with nasal CPAP therapy for sleep apnea. PERCEPT MOT SKILLS 1994; 78:1116-1118.
25. Derderian SS, Bridenbaugh RH, Rajagopal KR. Neuropsychological symptoms in obstructive sleep apnea improve after treatment with nasal continuous positive airway pressure. CHEST 1988; 94:1023-1027.
26. Bedard MA, Montplaisir J, Malo J, Richer F, Rouleau I. Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airway pressure. J CLIN EXP NEUROPSYCHOL 1993; 15:330-341.
27. Kiely JL, Murphy M, McNicholas WT. Subjective efficacy of nasal CPAP in the obstructive sleep apnoea syndrome: a prospective con-trolled study. Eur Resp J 1999 (IN PRESS).
28. Poceta, J.S., Dalessio, DJ. Identification and treatment of sleep apnea in patients with chronic headache. Headache. 1995; 35:586-589.
29. Ulfberg, J., Carter, N., Talback, M., Edling, C. Headache, snoring and sleep apnoea. J.Neurol. 1996; 243:621-625.
30. Graf, K.I., Karaus, M., Heinemann, S., Korber, S., Dorow, P., Ham-pel, K.E. Gastroesophageal reflux in patients with sleep apnea syn-drome. Z.Gastroenterol. 1995; 33:689-693.
31. Kerr, P., Shoenut, J.P., Millar, T., Buckle, P., Kryger, M.H. Nasal CPAP reduces gastroesophageal reflux in obstructive sleep apnea syndrome. Chest 1992; 101:1539-1544.
32. Follenius, M., Krieger, J., Krauth, M.O., Sforza, F., Brandenberger, G. Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone. Sleep. 1991; 14:211-217.
33. Krieger, J., Follenius, M., Sforza, E., Brandenberger, G., Peter, J.D. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci.(Colch.) 1991; 80:443-449.
34. Baruzzi, A., Riva, R., Cirignotta, F., Zucconi, M., Cappelli, M., Lugaresi, E. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep. 1991; 14:83-86.
35. Krieger, J., Petiau, C., Sforza, E., Delanoe, C., Hecht, M.T., Chamouard, V. Nocturnal polyuria is a symptom of obstructive sleep apnea. Urol.Int. 1993; 50:93-97.
36. Shepard, J.W., Jr. Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin.Chest Med. 1992; 13:437-458.
37. Carlson, J.T., Hedner, J.A., Ejnell, H., Peterson, L.E. High prevalence of hypertension in sleep apnea patients independent of obesity, AmJ.Respir.Crit.Care Med. 1994; 150:72-77.
38. Mooe, T., Rabben, T., Wiklund, U., Franklin, K.A., Eriksson, P. Sleep-disordered breathing in men with coronary artery disease. Chest 1996; 109:659-663.
39. Schafer, H., Koehler, U., Ploch, T., Peter, J.H. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 1997; 111:387-393.
40. Good, D.C., Henkle, J.Q., Gelber, D., Welsh, J., Verhulst, S. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996; 27:252-259.
41. He, J., Kryger, M.H., Zorick, F.J., Conway, W., Roth, T. Mortality and apnea index in obstructive sleep apnea. experience in 385 male patients. Chest 1988; 94:9-14.
42. Lavie, P., Herer, P., Peled, R., Berger, I., Yoffe, N., Zomer, J., et al Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep. 1995; 18:149-157.
43. Deegan PC, McNicholas WT. Predictive value of clinical features for the obstructive sleep apnoea syndrome. Eur Resp J 1996; 9:117-124.
44. J.M. Montserrat, E. Ballester, L. Hernandez. Overview of management options for snoring and sleep apnoea. IN: Respiratory disorders during sleep, (edited by WT McNicholas). European Respiratory Monographs. Volume 3 Munsgard Press. Copenhagen 1998: 144-178.
45. Lévy P, Bettega G, Pépin J.L. Surgical management options for snoring and sleep apnoea. IN: Respiratory disorders during sleep, (edited by WT McNicholas). European Respiratory Monographs. Volume 3 Munsgard Press. Copenhagen 1998: 205-226.
46. Lowe AA. Dental appliances for the treatment of snoring and/or obstructive sleep apnea. In: Kryger M, Roth T, Dement W, eds. Principles and practice of sleep medicine 2nd edition. Philadelphia: WB Saunders, 1994:722-35.
47. Schmidt-Nowara W, Lowe A, Wiegand L, Cartwriht R, Perez-Guerra F, Menn S. Oral appliances for the treatment of snoring and obstructive sleep apnea. A review. Sleep 1995; 18:501-10.